Gamma Biosciences Makes Strategic Investment in Process Analytics and Continuous Bioprocessing Company, Nirrin Technologies

September, 2021

Gamma Biosciences Names Terry Pizzie as CEO of Astrea Bioseparations

June, 2021

Gamma Biosciences Acquires Controlling Stake in Mirus Bio to Expand Reach in Gene Therapy and Next Generation Vaccines

May, 2021

Gamma Biosciences, a Life Sciences Tool Platform Created by KKR, Has Agreed to Acquire State College, Pennsylvania Based, BioMagnetic Solutions (BMS), a Next-Generation Cell Selection and Bioseparation Technology Company.

January, 2021

Gamma Biosciences Announces Strategic Licensing Agreement by Astrea Bioseparations for Advanced Application of Avacta Affimer® Reagent Technology

December, 2020

Gamma Biosciences Acquires Nanopareil to Advance Next-Generation Purification Capabilities of Astrea Bioseparations

September, 2020

Launch of Univercells Technologies for intensified, automated technologies

May, 2020

KKR Forms Life Sciences Tools Platform Gamma Biosciences

February, 2020

Astrea arises from the Prometic ashes; inks column deal with Thermo

January, 2020

BIO Digital

Accelerating a BIO-Revolution through global partnerships, collaboration, and thought leadership.

June 14-17, 2021

Biotech Week Boston

The Biotech event accelerating fresh ideas, partnerships and opportunities

September 20 – 23, 2021

ARM Meeting on the Mesa

The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures

October 12 – 14, 2021